187 related articles for article (PubMed ID: 24136402)
1. Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection.
Wang X; Blanchard J; Grundke-Iqbal I; Wegiel J; Deng HX; Siddique T; Iqbal K
Acta Neuropathol; 2014 Feb; 127(2):243-56. PubMed ID: 24136402
[TBL] [Abstract][Full Text] [Related]
2. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
Arnaud L; Chen S; Liu F; Li B; Khatoon S; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2011 Sep; 585(17):2653-9. PubMed ID: 21806989
[TBL] [Abstract][Full Text] [Related]
6. The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment.
Wang X; Blanchard J; Kohlbrenner E; Clement N; Linden RM; Radu A; Grundke-Iqbal I; Iqbal K
FASEB J; 2010 Nov; 24(11):4420-32. PubMed ID: 20651003
[TBL] [Abstract][Full Text] [Related]
7. Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice.
Liu GP; Wei W; Zhou X; Shi HR; Liu XH; Chai GS; Yao XQ; Zhang JY; Peng CX; Hu J; Li XC; Wang Q; Wang JZ
Mol Ther; 2013 Dec; 21(12):2247-57. PubMed ID: 23922015
[TBL] [Abstract][Full Text] [Related]
8. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
Arif M; Kazim SF; Grundke-Iqbal I; Garruto RM; Iqbal K
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1144-9. PubMed ID: 24395787
[TBL] [Abstract][Full Text] [Related]
9. An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide.
Bolognin S; Blanchard J; Wang X; Basurto-Islas G; Tung YC; Kohlbrenner E; Grundke-Iqbal I; Iqbal K
Acta Neuropathol; 2012 Jan; 123(1):133-51. PubMed ID: 22083255
[TBL] [Abstract][Full Text] [Related]
10. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
11. Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.
Perera ND; Sheean RK; Scott JW; Kemp BE; Horne MK; Turner BJ
PLoS One; 2014; 9(3):e90449. PubMed ID: 24595038
[TBL] [Abstract][Full Text] [Related]
12. Animal models of the sporadic form of Alzheimer's disease: focus on the disease and not just the lesions.
Iqbal K; Bolognin S; Wang X; Basurto-Islas G; Blanchard J; Tung YC
J Alzheimers Dis; 2013; 37(3):469-74. PubMed ID: 23948903
[TBL] [Abstract][Full Text] [Related]
13. β-amyloid triggers ALS-associated TDP-43 pathology in AD models.
Herman AM; Khandelwal PJ; Stanczyk BB; Rebeck GW; Moussa CE
Brain Res; 2011 Apr; 1386():191-9. PubMed ID: 21376022
[TBL] [Abstract][Full Text] [Related]
14. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.
Tanimukai H; Grundke-Iqbal I; Iqbal K
Am J Pathol; 2005 Jun; 166(6):1761-71. PubMed ID: 15920161
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.
Tsujio I; Zaidi T; Xu J; Kotula L; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2005 Jan; 579(2):363-72. PubMed ID: 15642345
[TBL] [Abstract][Full Text] [Related]
17. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
[TBL] [Abstract][Full Text] [Related]
18. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.
Chasseigneaux S; Clamagirand C; Huguet L; Gorisse-Hussonnois L; Rose C; Allinquant B
BMC Neurosci; 2014 Jun; 15():82. PubMed ID: 24981783
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration.
Kadokura A; Yamazaki T; Kakuda S; Makioka K; Lemere CA; Fujita Y; Takatama M; Okamoto K
Neurosci Lett; 2009 Sep; 463(1):87-92. PubMed ID: 19539703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
